科笛-B(02487.HK):2024年度收益同比增加103%至2.8億元
格隆匯3月24日丨科笛-B(02487.HK)發佈公吿,截至2024年12月31日止年度,收益同比增加約103%至約人民幣2.80億元,主要是由於毛髮疾病及護理產品及日常護膚產品的銷量增加。集團現有的銷售渠道已呈現初步規模效應,同時,集團在成本控制方面取得良好成效。截至2024年12月31日止年度,銷售及分銷開支佔收益比例較上年同期大幅下降;研發成本較上年同期下降約人民幣1700萬元或8%;行政開支較上年同期下降約人民幣4400萬元或24%。
截至2024年12月31日止年度,年內虧損及全面虧損總額較上年同期大幅下降。集團將持續優化經營效率,進一步收窄年內虧損及全面虧損總額佔收益的比例。截至2024年12月31日,集團的現金及現金等價物總額、三個月以上的定期存款及按公平值計入損益的金融資產為約人民幣8.76億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.